Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Immune-Inflammatory and Oxidative and Nitrosative Stress Biomarkers of Depression Symptoms in Subjects with Multiple Sclerosis: Increased Peripheral Inflammation but Less Acute Neuroinflammation.
Reviewing the role of Resveratrol as a natural modulator of microglial activities.
Hyaluronan Anchored to Activated CD44 on CNS Vascular Endothelial Cells Promotes Lymphocyte Extravasation in Experimental Autoimmune Encephalomyelitis.
The Encephalitogenic, Human Myelin Oligodendrocyte Glycoprotein-Induced Antibody Repertoire Is Directed towards Multiple Epitopes in C57BL/6-Immunized Mice.
Neuromyelitis optica.
Natalizumab-Induced Progressive Multifocal Leukoencephalopathy.
Is There Extra Cost of Institutional Care for MS Patients?
Multiple sclerosis : A multielement survey.
Eliminating Encephalitogenic T Cells without Undermining Protective Immunity.
Walking and cognition, but not symptoms, correlate with dual task cost of walking in multiple sclerosis.
Dual task cost of cognition is related to fall risk in patients with multiple sclerosis: A prospective study.
Relevance of the type I interferon signature in multiple sclerosis towards a personalized medicine approach for interferon-beta therapy.
Evaluation of brainstem involvement in multiple sclerosis.
Modelling the Cost Effectiveness of Disease-Modifying Treatments for Multiple Sclerosis : Issues to Consider.
Electroconvulsive therapy in patient with psychotic depression and multiple sclerosis.
Diffuse Granulomatous Inflammation Associated With Long-term Interferon-β Therapy.
Dimethyl fumarate associated lymphopenia in clinical practice.
Concise Review: Modeling Multiple Sclerosis With Stem Cell Biological Platforms: Toward Functional Validation of Cellular and Molecular Phenotypes in Inflammation-Induced Neurodegeneration.
Evaluating Neurocognitive Deficits in Patients with Multiple Sclerosis via a Brief Neuropsychological Approach.
Low prevalence of human herpesvirus-6 and varicella zoster virus in blood of multiple sclerosis patients, irrespective of inflammatory status or disease progression.
Autoimmune Aquaporin-4 Myopathy in Neuromyelitis Optica Spectrum.
The role of Toll-like receptors in multiple sclerosis and possible targeting for therapeutic purposes.
The membrane attack complex of complement causes severe demyelination associated with acute axonal injury.
The role of transcriptional control in multiple system atrophy.
C1-C2 X-Ray assessment of misalignment parameters in patients with Chronic Cerebra-spinal Venous Insufficiency and Multiple Sclerosis versus patients with other pathologies.
Pages
« first
‹ previous
…
430
431
432
433
434
435
436
437
438
…
next ›
last »